Ergoteles LLC Chroma Dex Corp. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.25 - $1.94 $126,301 - $196,019	-101,041 Reduced 79.43%	26,170 $43,000
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $122,675 - $212,363	-103,089 Reduced 44.76%	127,211 $156,000
Q2 2022 Aug 12, 2022	BUY	$1.59 - $2.7 $366,177 - $621,810	230,300 New	230,300 $385,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $81,070 - $139,494	-13,400 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.66 - $10.92 $89,244 - $146,328	13,400 New	13,400 $132,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.